Angiotensin-(1-7) in hypertension

被引:8
作者
Chappell, MC [1 ]
Ferrario, CM [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27157 USA
关键词
D O I
10.1097/00041552-199903000-00013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence suggests that angiotensin-(1-7) is a bioactive component of the renin-angiotensin system that may oppose or, in certain situations contribute to the actions of Ang II. Ang-(1-7) can be directly formed from Ang I bypassing the requisite production of Ang II. In contrast to forming Ang II, angiotensin-converting enzyme hydrolyses Ang-(1-7) to inactive fragments. Angiotensin-converting enzyme inhibitors substantially augment circulating levels of Ang-(1-7) and increase the peptide's half-life six-fold. Thus, angiotensin-converting enzyme may constitute an important regulatory point to balance the actions of Ang II, Ang-(1-7) and bradykinin. Indeed, Ang-(1-7) can potentiate the actions of bradykinin through a receptor-mediated site and a direct interaction with angiotensin-converting enzyme. We summarize recent studies that reveal depressor, vasodilator, and antihypertensive actions of Ang-(1-7) thus providing evidence that Ang-(1-7) is the antihypertensive peptide of the renin-angiotensin system. Curr Opin Nephrol Hypertens 8:231-235. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 37 条
  • [1] MODULATION OF PHOSPHOLIPASE-A2 ACTIVITY AND SODIUM-TRANSPORT BY ANGIOTENSIN-(1-7)
    ANDREATTAVANLEYEN, S
    ROMERO, MF
    KHOSLA, MC
    DOUGLAS, JG
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (05) : 932 - 936
  • [2] BARACHO NCV, 1995, HYPERTENSION, V25, P1408
  • [3] Metabolism of angiotension-(1-7) by angiotensin-converting enzyme
    Chappell, MC
    Pirro, NT
    Sykes, A
    Ferrario, CM
    [J]. HYPERTENSION, 1998, 31 (01) : 362 - 367
  • [4] Antihypertensive effects of angiotensin-(1-7)
    Chappell, MC
    Iyer, SN
    Diz, DI
    Ferrario, CM
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (09) : 1205 - 1212
  • [5] RECENT ADVANCES IN KNOWLEDGE OF THE STRUCTURE AND FUNCTION OF THE ANGIOTENSIN-I CONVERTING-ENZYME
    CORVOL, P
    MICHAUD, A
    SOUBRIER, F
    WILLIAMS, TA
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 : S3 - S10
  • [6] N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme angiotensin-(1-7) and Keto-ACE
    Deddish, PA
    Marcic, B
    Jackman, HL
    Wang, HZ
    Skidgel, RA
    Erdös, EG
    [J]. HYPERTENSION, 1998, 31 (04) : 912 - 917
  • [7] Deddish PA, 1996, J PHARMACOL EXP THER, V279, P1582
  • [8] DELLIPIZZI AM, 1994, BRIT J PHARMACOL, V111, P1
  • [9] Counterregulatory actions of angiotensin-(1-7)
    Ferrario, CM
    Chappell, MC
    Tallant, EA
    Brosnihan, KB
    Diz, DI
    [J]. HYPERTENSION, 1997, 30 (03) : 535 - 541
  • [10] FORTES ZB, 1998, FASEB J, V12, P2270